Filing Summary
Business Context and Reporting Period
LifeStance Health Group, Inc. filed a Form 8-K dated August 22, 2021, reporting a board appointment. The company is incorporated in Delaware, trades under the symbol LFST on Nasdaq, and identifies as an emerging growth company.
Key Financial Metrics
This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes
- Effective August 22, 2021, the Board appointed Seema Verma as a director.
- Ms. Verma received 79,543 restricted stock units under the company’s 2021 Equity Incentive Plan.
- The award vests under a time- and performance-based restricted stock unit agreement and is subject to her continued service on the Board.
Guidance, Outlook, Risks, and Unusual Items
The filing provides no financial guidance or operating outlook. The principal disclosed item is the equity award, whose ultimate vesting depends on continued board service and specified time- and performance-based conditions.
Investor Verification Items
- Verify the detailed vesting schedule and performance conditions in the restricted stock unit agreement.
- Assess the potential dilution from the 79,543 restricted stock units.
- Review subsequent filings for changes to Ms. Verma’s board service or equity award.